Overcoming the Causes (and Consequences) of Chronic Hyperkalemia

Annenberg Center for Health Sciences
  • 0.0 (0)
  • MEDICINE

Chronic hyperkalemia has several possible causes, including impaired renal excretion of potassium due to a decrease in mineralocorticoid activity, often resulting from renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. While limiting potassium intake and avoiding the use of RAASi therapy are common strategies to manage patients who develop chronic hyperkalemia, both have important negative consequences on patient outcomes, particularly related to the kidneys. Sodium polystyrene sulfonate has often been used to bind potassium, but limited effectiveness and gastrointestinal toxicity

Episodes

  1. Other Treatment Considerations

    02/04/2022

    Other Treatment Considerations

    Finerenone Team care

    7 min
  2. Potassium-binding Medications

    02/04/2022

    Potassium-binding Medications

    Safety & efficacy of patiromer Safety & efficacy of sodium zirconium cyclosilicate

    11 min
  3. RAAS Inhibitor Therapy

    02/04/2022

    RAAS Inhibitor Therapy

    Real-world use of RAAS inhibitor therapy Benefits & limitations of RAAS inhibitor therapy

    18 min
  4. Course Introduction

    02/04/2022

    Course Introduction

    Potassium homeostasis Differential diagnosis of hyperkalemia Consequences of hyperkalemia

    13 min
  5. Faculty Introduction

    02/04/2022

    Faculty Introduction

    Biff F. Palmer, MD Professor of Internal Medicine UT Southwestern Medical Center Dallas, Texas

    1 min
  • 5 Episodes

About

Chronic hyperkalemia has several possible causes, including impaired renal excretion of potassium due to a decrease in mineralocorticoid activity, often resulting from renin-angiotensin-aldosterone system inhibitor (RAASi) therapy. While limiting potassium intake and avoiding the use of RAASi therapy are common strategies to manage patients who develop chronic hyperkalemia, both have important negative consequences on patient outcomes, particularly related to the kidneys. Sodium polystyrene sulfonate has often been used to bind potassium, but limited effectiveness and gastrointestinal toxicity

Information